(Press-News.org)
ŌURA, maker of the most scientifically validated smart ring, Oura Ring, and the Centre for Sleep and Cognition (CSC) at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), today announced the opening of the Oura–NUS Joint Lab, a new research entity dedicated to advancing personalised preventive health.
Located at NUS, the Joint Lab will advance scientific research by combining continuous, real‑world biometric data from ŌURA within approved research studies with NUS’s decades-long expertise in sleep science, physiological data analysis, and cognitive neuroscience to study how sleep and physical activity shape other areas of health and drive better health outcomes. The Joint Lab aims to generate insights that help individuals, clinicians, and health systems shift from reactive care to proactive, preventive health.
Building on a proven collaboration
ŌURA and NUS have collaborated for more than six years across multiple research projects, including evaluating the accuracy of Oura Ring’s sleep tracking[1][2][3][4], characterising multi-country differences in nocturnal sleep variability[5], exploring effects of travel-related sleep disruption[6] and investigating how day‑to‑day shifts in wearable biometric data can inform about cardiovascular health and disease risk.[7]
The new Joint lab will expand this work by designing and running multi-year studies that use Oura Ring’s continuous data to understand how real‑world sleep and daily behaviours influence long‑term health outcomes, both at the individual and population levels.
“Changing health habits is notoriously difficult, and doing it well requires robust science and accurate, continuous data,” said Dr Shyamal Patel, Senior Vice President of Science at ŌURA. “Our long‑standing collaboration with NUS has already shown how high‑quality wearable data can deepen our understanding of cardiovascular, metabolic, and mental health. With this Joint Lab, we’re expanding that work to tackle some of the world’s most pressing preventive health challenges.”
Singapore as a hub for global preventive health
The Joint Lab is the first research entity in APAC for ŌURA, underscoring the company’s commitment to the region and recognition of Singapore as a strategic hub for international growth, health innovation, and public–private collaboration. By anchoring this work in Singapore, the partners aim to contribute to national priorities around preventive health and healthy longevity and build data-driven models that can be scaled across APAC and global populations.
“The Joint Lab will accelerate the realisation of our shared goal of reducing the burden of chronic disease,” said Professor Michael Chee, Director, Centre for Sleep and Cognition at NUS Medicine. “By pairing Ōura’s continuous biometric data with our expertise in sleep science and behaviour change, we can test new ways of giving people timely and relevant feedback that help them make optimal lifestyle choices every day for better health outcomes.”
“Ōura’s decision to set up a joint lab in Singapore builds on the strong foundation of its long-standing collaboration with NUS. This is Ōura’s first presence in Asia and reflects Singapore’s strong base of talent, research, and innovation capabilities, as well as the growing market opportunities in preventive health," said Ms Goh Wan Yee, Senior Vice President and Head, Healthcare, Singapore Economic Development Board.
For media enquiries, please contact:
Xuan LEE
Manager, Communications
Yong Loo Lin School of Medicine,
National University of Singapore
DID: +65 8288-1237
Email: lxuan@nus.edu.sg
Jamie HILL
Director of Communications
ŌURA
Email: jamie.hill@ouraring.com
[1] Multi-Night Validation of a Sleep Tracking Ring in Adolescents Compared with a Research Actigraph and Polysomnography
[2] Improved sleep detection & classification with sleep tracker | NSS
[3] Selecting a sleep tracker from EEG-based, iteratively improved, low-cost multisensor, and actigraphy-only devices - ScienceDirect
[4] Performance of wearable sleep trackers during nocturnal sleep and periods of simulated real-world smartphone use - ScienceDirect
[5] Country differences in nocturnal sleep variability: Observations from a large-scale, long-term sleep wearable study - ScienceDirect
[6] Insights about travel-related sleep disruption from 1.5 million nights of data
[7] RESET Collaborates with ŌURA to Transform Preventive Cardiovascular Health Through AI-Powered Wearable Insights - The Pulse Blog
END
When lung cancer treatment stops working, what happens next? New research reveals the answer may depend on how the cancer grows.
Medical researchers at Flinders University have uncovered an important clue that could help doctors better predict what happens next for people with advanced lung cancer when their first treatment fails.
Researchers looked at thousands of patients with non-small cell lung cancer (NSCLC) treated with modern chemoimmunotherapy – a combination of chemotherapy and immunotherapy - that has become a standard first-line treatment.
The study, published in the journal Cancer Letters, is the first to apply a modified classification ...
22 JANUARY 2026
SINGAPORE – Scientists from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) have identified why certain lung cancer cells become highly resistant to treatment after developing mutations in a key gene called EGFR (epidermal growth factor receptor). In a study published in Science Advances, the researchers revealed a previously unknown survival mechanism and demonstrated that disrupting it can shrink tumours in laboratory models.
Lung cancer is the leading cause of cancer deaths globally. Many cases are driven by mutations in the EGFR gene, which causes cells to grow and divide uncontrollably. In Southeast Asia, these mutations are found in ...
How can bacteria squeeze through spaces narrower than a human hair is thick? A research team in Japan led by Dr. Daisuke Nakane and Dr. Tetsuo Kan at the University of Electro-Communications, Dr. Hirofumi Wada at Ritsumeikan University, and Dr. Yoshitomo Kikuchi at National Institute of Advanced Industrial Science and Technology have revealed the answer: they drill their way through.
The study, published in Nature Communications, shows that certain symbiotic bacteria wrap their rotating flagella—the helical tails used for swimming—around their cell bodies to form a “screw thread.” This configuration lets them propel forward through one-micrometer-wide passages, such ...
LOGAN, Utah, USA — A recent critique from a team led by Utah State University ecologist Dan MacNulty and published in Forest Ecology and Management has prompted a formal correction to a high-profile study on aspen recovery while raising broader questions about how scientific conclusions are drawn and defended in complex ecological systems.
The original study, published last year by Luke Painter and colleagues, concluded that restoration of large carnivores — including the reintroduction of wolves in the mid-1990s — triggered a strong, ecologically significant trophic cascade that fostered widespread recovery of aspen trees in northern Yellowstone. Central to their evidence ...
Gaps in the nation’s stroke transfer system are drastically reducing survivors’ chances of receiving critical treatment and increasing the likelihood that they will leave the hospital with a disability, a new study suggests.
Around one-third of ischemic stroke survivors are eligible for endovascular thrombectomy, an effective intervention that changed the landscape of stroke treatment more than a decade ago.
More than 40% of people who receive endovascular therapy are initially seen at hospitals that don’t offer the treatment. These patients require transfer to more advanced facilities capable of delivering thrombectomy.
New findings published in The Lancet ...
Gaps in the U.S. stroke transfer system are drastically reducing survivors’ chances of receiving critical treatment and increasing the likelihood that they will leave the hospital with a disability, according to a new study published in The Lancet Neurology.
Around one-third of ischemic stroke patients are eligible for endovascular thrombectomy, an effective intervention that changed the landscape of stroke treatment more than a decade ago.
More than 40% of people who receive endovascular therapy initially arrive at hospitals that don’t offer the treatment. These patients require transfer to more advanced facilities capable of delivering ...
The long term use of proton pump inhibitors (PPIs), a class of drugs widely used to treat acid reflux and ulcers, may not be linked to any increased risk of developing gastric (stomach) cancer, finds a study of Nordic health data published by The BMJ today.
This finding should offer relief for patients needing long term proton pump inhibitor therapy and is valuable for clinical decision making in healthcare settings, say the researchers.
A fear that proton pump inhibitors could lead to stomach cancer has been ongoing since the 1980s. Recent research has linked their use to around a twofold increased risk, but ...
Offering non-monetary incentives such as free access to outpatient consultations to frequent blood donors is linked to an increase in donations without compromising blood safety, finds a study from China published by The BMJ today.
The researchers say their findings could encourage policymakers in other countries to design their own incentive models to address blood shortages.
Many countries, particularly developing ones, struggle to sustain an adequate blood supply due to challenges of retaining blood donors under the “gift model” - a ...
Natural ovulation before frozen embryo transfer is as effective as hormone treatment for achieving a healthy baby by vitro fertilisation (IVF), finds a clinical trial from China published by The BMJ today.
Natural ovulation is also linked to a lower risk of several complications for the mother, such as pre-eclampsia (abnormally high blood pressure), the results show.
Globally, the use of frozen embryo transfer after IVF has increased substantially and accounts for more than 60% of all embryo transfers.
Doctors prepare the womb lining (endometrium) for frozen ...
A major UK clinical trial has shown that adding the corticosteroid dexamethasone to standard antiviral treatment for encephalitis (brain inflammation), caused by herpes simplex virus (HSV) does not improve long-term outcomes overall, although early use may lead to better recovery, and the treatment is safe for patients in whom encephalitis is suspected.
The DexEnceph study, led by researchers at The Pandemic Institute, the University of Liverpool, and Walton Centre NHS Foundation Trust in partnership with Encephalitis International and research teams around the country, provides the most definitive evidence so far on whether corticosteroids should be used ...
